Lifecore Biomedical, Inc. (LFCR) Q3 2024 Annual Earnings
LFCR·Reported August 26, 2024·Before market open
Lifecore Biomedical, Inc. reported Q3 2024 revenue of $24.7M, missed analyst consensus of $29.7M by $5.0M. Diluted EPS came in at $-0.15, missed the $-0.12 consensus by $0.03.
Revenue
$24.7Mmissed by $5.0M
Consensus: $29.7MDiluted EPS
$-0.15missed by $0.03
Consensus: $-0.12
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Lifecore Biomedical, Inc.'s Q3 2024 earnings report.
Lifecore Biomedical, Inc. (LFCR) reported Q3 2024 earnings on August 26, 2024 before market open.
Lifecore Biomedical, Inc. reported revenue of $24.7M and diluted EPS of $-0.15 for Q3 2024.
Revenue missed the consensus estimate of $29.7M by $5.0M. EPS missed the consensus estimate of $-0.12 by $0.03.
You can read the 10-K periodic report (0001005286-24-000124) directly on SEC EDGAR. The filing index links above go to sec.gov.